Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the
last 20 years, much experience has been gained in measurement and interpretation of these …

Fibrous Dysplasia: Pathophysiology, Evaluation, and Treatmen... : JBJS Fibrous Dysplasia:
Pathophysiology, Evaluation, and Treatment : JBJS JBJS Journal Case Connector Reviews …

This WHO classification covers tumors of soft tissue and bone including inherited tumor
syndromes. Each entity is extensively discussed with information on clinicopathological …

FGF-23, a novel member of the FGF family, is the product of the gene mutated in autosomal
dominant hypophosphatemic rickets (ADHR). FGF-23 has been proposed as a circulating …

Maxillofacial fibro-osseous lesions (FOL) consists of lesions that differ, with the exception of
fibrous dysplasia, to those found in the rest of the skeleton. FOLs of the face and jaws are …

Bones consist of a variety of mesenchymal tissues, any one of which has the potential to
undergo neoplastic transformation. Primary tumors of bones may therefore be derived from …

Fibrous dysplasia has been regarded as a developmental skeletal disorder characterized by
replacement of normal bone with benign cellular fibrous connective tissue. It has now …

Gene therapy holds great promise in the treatment of genetic diseases. It is now possible to
make DNA modifications using the CRISPR system. However, a major problem remains: the …

Fibrous dysplasia is a developmental disorder of bone that can present in a monostotic or
polyostotic form. Primarily affecting adolescents and young adults, it accounts for 7% of …

An instrument to measure skeletal burden in fibrous dysplasia was developed. Biological
and clinical relevance was shown by correlating skeletal burden scores with bone markers …